News
XTuit Pharmaceuticals
XTuit Pharmaceuticals Closes $22M Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders
XTuit Pharmaceuticals Closes $22M Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders